Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.
Aurora Therapeutics today announced its official launch to transform personalized gene editing from a one-patient breakthrough into a scalable model capable of bringing therapies to millions of ...
Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...
CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...
10don MSN
Contrarius Global Equity Fund’s thoughts on CRISPR Therapeutics’ (CRSP) gene editing therapy
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback